

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 5.25925555 |
| 2 | central nervous system myelination (GO:0022010) | 5.25925555 |
| 3 | fatty acid elongation (GO:0030497) | 4.30586037 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 3.84010089 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.84010089 |
| 6 | behavioral response to nicotine (GO:0035095) | 3.82724670 |
| 7 | activated T cell proliferation (GO:0050798) | 3.42345983 |
| 8 | L-phenylalanine metabolic process (GO:0006558) | 3.37734968 |
| 9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.37734968 |
| 10 | axon ensheathment (GO:0008366) | 3.35953394 |
| 11 | ensheathment of neurons (GO:0007272) | 3.35953394 |
| 12 | myelination (GO:0042552) | 3.35896360 |
| 13 | postsynaptic membrane organization (GO:0001941) | 3.34827393 |
| 14 | response to methylmercury (GO:0051597) | 3.22928709 |
| 15 | L-amino acid import (GO:0043092) | 3.10514167 |
| 16 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.09235354 |
| 17 | negative regulation of neurotransmitter transport (GO:0051589) | 3.02346338 |
| 18 | neuron cell-cell adhesion (GO:0007158) | 3.01371955 |
| 19 | cAMP catabolic process (GO:0006198) | 3.01049421 |
| 20 | locomotory exploration behavior (GO:0035641) | 2.99531508 |
| 21 | membrane depolarization during action potential (GO:0086010) | 2.99153035 |
| 22 | adenosine receptor signaling pathway (GO:0001973) | 2.97211817 |
| 23 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.96318960 |
| 24 | glycerophospholipid catabolic process (GO:0046475) | 2.93189000 |
| 25 | aromatic amino acid family catabolic process (GO:0009074) | 2.92350417 |
| 26 | synaptic vesicle maturation (GO:0016188) | 2.92114927 |
| 27 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.91340777 |
| 28 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.88843981 |
| 29 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.84934080 |
| 30 | bile acid biosynthetic process (GO:0006699) | 2.82284331 |
| 31 | startle response (GO:0001964) | 2.81466541 |
| 32 | very long-chain fatty acid metabolic process (GO:0000038) | 2.80094423 |
| 33 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.78569632 |
| 34 | L-fucose catabolic process (GO:0042355) | 2.78563108 |
| 35 | fucose catabolic process (GO:0019317) | 2.78563108 |
| 36 | L-fucose metabolic process (GO:0042354) | 2.78563108 |
| 37 | regulation of neurotransmitter uptake (GO:0051580) | 2.78381653 |
| 38 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.75694992 |
| 39 | detection of light stimulus involved in visual perception (GO:0050908) | 2.75391613 |
| 40 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.75391613 |
| 41 | alpha-linolenic acid metabolic process (GO:0036109) | 2.75313173 |
| 42 | protein K11-linked deubiquitination (GO:0035871) | 2.72295751 |
| 43 | serotonin metabolic process (GO:0042428) | 2.72207518 |
| 44 | auditory behavior (GO:0031223) | 2.71789659 |
| 45 | neuronal action potential propagation (GO:0019227) | 2.71659771 |
| 46 | gamma-aminobutyric acid transport (GO:0015812) | 2.71400088 |
| 47 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.68748745 |
| 48 | synaptic transmission, glutamatergic (GO:0035249) | 2.67063815 |
| 49 | indole-containing compound catabolic process (GO:0042436) | 2.66288580 |
| 50 | indolalkylamine catabolic process (GO:0046218) | 2.66288580 |
| 51 | tryptophan catabolic process (GO:0006569) | 2.66288580 |
| 52 | indolalkylamine metabolic process (GO:0006586) | 2.65193451 |
| 53 | proline transport (GO:0015824) | 2.64817530 |
| 54 | presynaptic membrane organization (GO:0097090) | 2.64728061 |
| 55 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.64681348 |
| 56 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.64617936 |
| 57 | DNA deamination (GO:0045006) | 2.63503518 |
| 58 | neural tube formation (GO:0001841) | 2.63286962 |
| 59 | negative regulation of protein localization to cell surface (GO:2000009) | 2.63179700 |
| 60 | neuronal action potential (GO:0019228) | 2.62931831 |
| 61 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.62191956 |
| 62 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.61002390 |
| 63 | myelin maintenance (GO:0043217) | 2.60203646 |
| 64 | presynaptic membrane assembly (GO:0097105) | 2.60131952 |
| 65 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.59836429 |
| 66 | glutamate metabolic process (GO:0006536) | 2.58467686 |
| 67 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.57007826 |
| 68 | transmission of nerve impulse (GO:0019226) | 2.55767995 |
| 69 | establishment of protein localization to Golgi (GO:0072600) | 2.55137487 |
| 70 | primary amino compound metabolic process (GO:1901160) | 2.54936293 |
| 71 | auditory receptor cell stereocilium organization (GO:0060088) | 2.53420395 |
| 72 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.53408440 |
| 73 | adult walking behavior (GO:0007628) | 2.52612738 |
| 74 | cholesterol biosynthetic process (GO:0006695) | 2.52280362 |
| 75 | reflex (GO:0060004) | 2.51837676 |
| 76 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.51802278 |
| 77 | nerve growth factor signaling pathway (GO:0038180) | 2.50936716 |
| 78 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.49784228 |
| 79 | coenzyme catabolic process (GO:0009109) | 2.48209795 |
| 80 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.47544514 |
| 81 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.46906876 |
| 82 | kidney morphogenesis (GO:0060993) | 2.45818268 |
| 83 | C4-dicarboxylate transport (GO:0015740) | 2.45248565 |
| 84 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.44763017 |
| 85 | indole-containing compound metabolic process (GO:0042430) | 2.44695746 |
| 86 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.42599393 |
| 87 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.42038602 |
| 88 | bile acid metabolic process (GO:0008206) | 2.41953851 |
| 89 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.41329864 |
| 90 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.40936271 |
| 91 | negative regulation of cell killing (GO:0031342) | 2.40936271 |
| 92 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.40611170 |
| 93 | acyl-CoA biosynthetic process (GO:0071616) | 2.40330599 |
| 94 | thioester biosynthetic process (GO:0035384) | 2.40330599 |
| 95 | synaptic vesicle exocytosis (GO:0016079) | 2.40283381 |
| 96 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.39857608 |
| 97 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.39699412 |
| 98 | nucleobase catabolic process (GO:0046113) | 2.39531540 |
| 99 | potassium ion import (GO:0010107) | 2.38270696 |
| 100 | nonmotile primary cilium assembly (GO:0035058) | 2.38019659 |
| 101 | retinal cone cell development (GO:0046549) | 2.37624912 |
| 102 | kynurenine metabolic process (GO:0070189) | 2.37522270 |
| 103 | establishment of mitochondrion localization (GO:0051654) | 2.37280447 |
| 104 | glutamate secretion (GO:0014047) | 2.35774307 |
| 105 | vocalization behavior (GO:0071625) | 2.35638573 |
| 106 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.34830213 |
| 107 | cellular ketone body metabolic process (GO:0046950) | 2.34479950 |
| 108 | dicarboxylic acid catabolic process (GO:0043649) | 2.33453679 |
| 109 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.33322943 |
| 110 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.33172528 |
| 111 | high-density lipoprotein particle remodeling (GO:0034375) | 2.33108893 |
| 112 | cholesterol efflux (GO:0033344) | 2.32333075 |
| 113 | glycosphingolipid biosynthetic process (GO:0006688) | 2.32291441 |
| 114 | tryptophan metabolic process (GO:0006568) | 2.31021694 |
| 115 | urinary tract smooth muscle contraction (GO:0014848) | 2.30370488 |
| 116 | amino acid import (GO:0043090) | 2.29659803 |
| 117 | adaptation of signaling pathway (GO:0023058) | 2.29612936 |
| 118 | heme transport (GO:0015886) | 2.29316000 |
| 119 | regulation of lipoprotein metabolic process (GO:0050746) | 2.28650434 |
| 120 | atrial cardiac muscle cell action potential (GO:0086014) | 2.28218530 |
| 121 | protein localization to cilium (GO:0061512) | 2.28110543 |
| 122 | oligodendrocyte differentiation (GO:0048709) | 2.27496114 |
| 123 | mating behavior (GO:0007617) | 2.26847122 |
| 124 | iron coordination entity transport (GO:1901678) | 2.26832036 |
| 125 | behavioral response to cocaine (GO:0048148) | 2.26448677 |
| 126 | mechanosensory behavior (GO:0007638) | 2.26171150 |
| 127 | glycine transport (GO:0015816) | 2.25915442 |
| 128 | potassium ion transmembrane transport (GO:0071805) | 2.25483268 |
| 129 | cellular potassium ion transport (GO:0071804) | 2.25483268 |
| 130 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.25129263 |
| 131 | cellular potassium ion homeostasis (GO:0030007) | 2.25024858 |
| 132 | neuronal ion channel clustering (GO:0045161) | 2.24830240 |
| 133 | cellular response to interleukin-15 (GO:0071350) | 2.24694337 |
| 134 | membrane depolarization (GO:0051899) | 2.24583783 |
| 135 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.24384658 |
| 136 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.23888342 |
| 137 | short-chain fatty acid metabolic process (GO:0046459) | 2.23880783 |
| 138 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.23199165 |
| 139 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.23165723 |
| 140 | dendritic spine morphogenesis (GO:0060997) | 2.22354204 |
| 141 | long-term memory (GO:0007616) | 2.21911107 |
| 142 | neurotransmitter secretion (GO:0007269) | 2.21890780 |
| 143 | creatine metabolic process (GO:0006600) | 2.21423754 |
| 144 | protein targeting to Golgi (GO:0000042) | 2.21224996 |
| 145 | negative regulation of adenylate cyclase activity (GO:0007194) | 2.21157223 |
| 146 | action potential (GO:0001508) | 2.20055409 |
| 147 | regulation of synapse structural plasticity (GO:0051823) | 2.18785106 |
| 148 | neuron-neuron synaptic transmission (GO:0007270) | 2.18152825 |
| 149 | sterol biosynthetic process (GO:0016126) | 2.17959996 |
| 150 | reverse cholesterol transport (GO:0043691) | 2.17620978 |
| 151 | regulation of memory T cell differentiation (GO:0043380) | 2.17271795 |
| 152 | potassium ion transport (GO:0006813) | 2.17116477 |
| 153 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.17032386 |
| 154 | protein carboxylation (GO:0018214) | 2.17032386 |
| 155 | negative regulation of lipase activity (GO:0060192) | 2.16946203 |
| 156 | neuromuscular synaptic transmission (GO:0007274) | 2.16746633 |
| 157 | complement activation, alternative pathway (GO:0006957) | 2.16601588 |
| 158 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.16385484 |
| 159 | regulation of neurotransmitter transport (GO:0051588) | 2.15945324 |
| 160 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.15578129 |
| 161 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.15578129 |
| 162 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.15578129 |
| 163 | glutamate receptor signaling pathway (GO:0007215) | 2.15442432 |
| 164 | axoneme assembly (GO:0035082) | 2.15233658 |
| 165 | regulation of action potential (GO:0098900) | 2.15186921 |
| 166 | regulation of synaptic vesicle transport (GO:1902803) | 2.15033621 |
| 167 | cysteine metabolic process (GO:0006534) | 2.15010441 |
| 168 | protein localization to synapse (GO:0035418) | 2.14605250 |
| 169 | prepulse inhibition (GO:0060134) | 2.13966276 |
| 170 | cyclic nucleotide catabolic process (GO:0009214) | 2.13783621 |
| 171 | response to auditory stimulus (GO:0010996) | 2.13204283 |
| 172 | neuromuscular process controlling balance (GO:0050885) | 2.13171697 |
| 173 | import into cell (GO:0098657) | 2.11791660 |
| 174 | membrane tubulation (GO:0097320) | 2.11275925 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.86249917 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.79087572 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.68043506 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.35534696 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.28772537 |
| 6 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.25517466 |
| 7 | VDR_22108803_ChIP-Seq_LS180_Human | 2.23230861 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02404848 |
| 9 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.01382730 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.99538080 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.98170896 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.97835823 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.97052615 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.94917768 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.94917768 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.94287512 |
| 17 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.88043947 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.85459444 |
| 19 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.81721095 |
| 20 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.81615148 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79555941 |
| 22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.78760153 |
| 23 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.78151715 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.75836741 |
| 25 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.73855355 |
| 26 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.70737760 |
| 27 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.66737473 |
| 28 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.65642640 |
| 29 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.64809494 |
| 30 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.64083068 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64064226 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.56474232 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55080439 |
| 34 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.51471665 |
| 35 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.51263606 |
| 36 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.50000449 |
| 37 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.49121249 |
| 38 | FUS_26573619_Chip-Seq_HEK293_Human | 1.47431035 |
| 39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.47112879 |
| 40 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.46873756 |
| 41 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.46410626 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.44275370 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43226991 |
| 44 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.38146937 |
| 45 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38146937 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36969056 |
| 47 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.36782557 |
| 48 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32440324 |
| 49 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.31468730 |
| 50 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29283401 |
| 51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.28601434 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27449526 |
| 53 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.27204642 |
| 54 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.26643790 |
| 55 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.26227233 |
| 56 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.26092774 |
| 57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.25831270 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.24448575 |
| 59 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.23996007 |
| 60 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.23392410 |
| 61 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.23392410 |
| 62 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23034011 |
| 63 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.21194357 |
| 64 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20556272 |
| 65 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.19582049 |
| 66 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.19523460 |
| 67 | EWS_26573619_Chip-Seq_HEK293_Human | 1.18941680 |
| 68 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18884220 |
| 69 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.18690723 |
| 70 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.18455752 |
| 71 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18361552 |
| 72 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.18315092 |
| 73 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17793044 |
| 74 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.17705768 |
| 75 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.17675490 |
| 76 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16317284 |
| 77 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.16313593 |
| 78 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.16313593 |
| 79 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.15935689 |
| 80 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.15904614 |
| 81 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.14855587 |
| 82 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.14400941 |
| 83 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14094758 |
| 84 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12566058 |
| 85 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.11982242 |
| 86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11847696 |
| 87 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.11838381 |
| 88 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11780667 |
| 89 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10111876 |
| 90 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.10084967 |
| 91 | P300_19829295_ChIP-Seq_ESCs_Human | 1.09162627 |
| 92 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09035181 |
| 93 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08899549 |
| 94 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08795356 |
| 95 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08652299 |
| 96 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.08253501 |
| 97 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.07929835 |
| 98 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.06468053 |
| 99 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.06232946 |
| 100 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.06219991 |
| 101 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.06055055 |
| 102 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.05066382 |
| 103 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04968869 |
| 104 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.04746192 |
| 105 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.04746192 |
| 106 | KDM2B_26808549_Chip-Seq_REH_Human | 1.04365864 |
| 107 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04137074 |
| 108 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.03131314 |
| 109 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.02933103 |
| 110 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.02916970 |
| 111 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.02604479 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01352387 |
| 113 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99111764 |
| 114 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98519384 |
| 115 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97366920 |
| 116 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.96264944 |
| 117 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.94813747 |
| 118 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93539311 |
| 119 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.92926882 |
| 120 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.92610195 |
| 121 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.91953579 |
| 122 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.91631750 |
| 123 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.91429132 |
| 124 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90974942 |
| 125 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90460087 |
| 126 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89833983 |
| 127 | AR_25329375_ChIP-Seq_VCAP_Human | 0.89785399 |
| 128 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.89298143 |
| 129 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.87402589 |
| 130 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.86434496 |
| 131 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.86234704 |
| 132 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86211891 |
| 133 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.84602548 |
| 134 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83903041 |
| 135 | TP53_16413492_ChIP-PET_HCT116_Human | 0.83082091 |
| 136 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.82734860 |
| 137 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.81733292 |
| 138 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.81052809 |
| 139 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.80914498 |
| 140 | AR_19668381_ChIP-Seq_PC3_Human | 0.80828908 |
| 141 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.80709475 |
| 142 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.80096558 |
| 143 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.79843542 |
| 144 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.79478884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.46867572 |
| 2 | MP0002822_catalepsy | 3.72539152 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 3.60685904 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.52973509 |
| 5 | MP0003880_abnormal_central_pattern | 3.42759044 |
| 6 | MP0000920_abnormal_myelination | 3.07433544 |
| 7 | MP0003690_abnormal_glial_cell | 3.00224821 |
| 8 | MP0005360_urolithiasis | 2.92938350 |
| 9 | MP0004270_analgesia | 2.92025963 |
| 10 | MP0003787_abnormal_imprinting | 2.89140074 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.86337641 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.74144254 |
| 13 | MP0003329_amyloid_beta_deposits | 2.53118330 |
| 14 | MP0003635_abnormal_synaptic_transmissio | 2.45542424 |
| 15 | MP0002064_seizures | 2.34838570 |
| 16 | MP0009745_abnormal_behavioral_response | 2.29237146 |
| 17 | MP0005365_abnormal_bile_salt | 2.28500276 |
| 18 | MP0008877_abnormal_DNA_methylation | 2.27529004 |
| 19 | MP0001486_abnormal_startle_reflex | 2.25726993 |
| 20 | MP0002272_abnormal_nervous_system | 2.11672145 |
| 21 | MP0002063_abnormal_learning/memory/cond | 1.98896745 |
| 22 | MP0001986_abnormal_taste_sensitivity | 1.97733520 |
| 23 | MP0009840_abnormal_foam_cell | 1.97562490 |
| 24 | MP0004885_abnormal_endolymph | 1.91777250 |
| 25 | MP0000604_amyloidosis | 1.91479636 |
| 26 | MP0003724_increased_susceptibility_to | 1.87291164 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 1.81569531 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.81433250 |
| 29 | MP0002572_abnormal_emotion/affect_behav | 1.76216504 |
| 30 | MP0009046_muscle_twitch | 1.72875822 |
| 31 | MP0003195_calcinosis | 1.71876685 |
| 32 | MP0002734_abnormal_mechanical_nocicepti | 1.69126726 |
| 33 | MP0005174_abnormal_tail_pigmentation | 1.68232904 |
| 34 | MP0005423_abnormal_somatic_nervous | 1.65136615 |
| 35 | MP0001984_abnormal_olfaction | 1.63357175 |
| 36 | MP0003633_abnormal_nervous_system | 1.57697387 |
| 37 | MP0003252_abnormal_bile_duct | 1.55996447 |
| 38 | MP0001529_abnormal_vocalization | 1.54423093 |
| 39 | MP0003646_muscle_fatigue | 1.54065330 |
| 40 | MP0005058_abnormal_lysosome_morphology | 1.53232924 |
| 41 | MP0002638_abnormal_pupillary_reflex | 1.51987982 |
| 42 | MP0010329_abnormal_lipoprotein_level | 1.51118147 |
| 43 | MP0001905_abnormal_dopamine_level | 1.49812312 |
| 44 | MP0002876_abnormal_thyroid_physiology | 1.49121832 |
| 45 | MP0003806_abnormal_nucleotide_metabolis | 1.49091292 |
| 46 | MP0002102_abnormal_ear_morphology | 1.47300139 |
| 47 | MP0003634_abnormal_glial_cell | 1.47188010 |
| 48 | MP0002736_abnormal_nociception_after | 1.46796086 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.44040016 |
| 50 | MP0001440_abnormal_grooming_behavior | 1.43455117 |
| 51 | MP0000427_abnormal_hair_cycle | 1.43322071 |
| 52 | MP0005671_abnormal_response_to | 1.41989139 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.41296068 |
| 54 | MP0005645_abnormal_hypothalamus_physiol | 1.36691464 |
| 55 | MP0003075_altered_response_to | 1.35243920 |
| 56 | MP0002229_neurodegeneration | 1.34411514 |
| 57 | MP0004142_abnormal_muscle_tone | 1.34249940 |
| 58 | MP0003631_nervous_system_phenotype | 1.33687143 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.32452488 |
| 60 | MP0002118_abnormal_lipid_homeostasis | 1.31856623 |
| 61 | MP0001666_abnormal_nutrient_absorption | 1.30836688 |
| 62 | MP0001970_abnormal_pain_threshold | 1.30096175 |
| 63 | MP0004043_abnormal_pH_regulation | 1.29177512 |
| 64 | MP0004924_abnormal_behavior | 1.29051791 |
| 65 | MP0005386_behavior/neurological_phenoty | 1.29051791 |
| 66 | MP0002735_abnormal_chemical_nociception | 1.28735398 |
| 67 | MP0005083_abnormal_biliary_tract | 1.26376526 |
| 68 | MP0004742_abnormal_vestibular_system | 1.25622660 |
| 69 | MP0002090_abnormal_vision | 1.24995441 |
| 70 | MP0005409_darkened_coat_color | 1.24595383 |
| 71 | MP0004147_increased_porphyrin_level | 1.24435624 |
| 72 | MP0002067_abnormal_sensory_capabilities | 1.23987250 |
| 73 | MP0002733_abnormal_thermal_nociception | 1.23068221 |
| 74 | MP0005332_abnormal_amino_acid | 1.22780926 |
| 75 | MP0005646_abnormal_pituitary_gland | 1.20961484 |
| 76 | MP0005253_abnormal_eye_physiology | 1.20587857 |
| 77 | MP0000778_abnormal_nervous_system | 1.20129727 |
| 78 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.16308769 |
| 79 | MP0003632_abnormal_nervous_system | 1.15869054 |
| 80 | MP0002928_abnormal_bile_duct | 1.15122872 |
| 81 | MP0008569_lethality_at_weaning | 1.13782757 |
| 82 | MP0008874_decreased_physiological_sensi | 1.11722561 |
| 83 | MP0000015_abnormal_ear_pigmentation | 1.07779804 |
| 84 | MP0002066_abnormal_motor_capabilities/c | 1.06323764 |
| 85 | MP0003879_abnormal_hair_cell | 1.05153520 |
| 86 | MP0010386_abnormal_urinary_bladder | 1.04722466 |
| 87 | MP0006072_abnormal_retinal_apoptosis | 1.03694275 |
| 88 | MP0006082_CNS_inflammation | 1.03380630 |
| 89 | MP0005535_abnormal_body_temperature | 1.03172084 |
| 90 | MP0000955_abnormal_spinal_cord | 1.02698135 |
| 91 | MP0001177_atelectasis | 1.01906730 |
| 92 | MP0002909_abnormal_adrenal_gland | 1.00596579 |
| 93 | MP0002557_abnormal_social/conspecific_i | 1.00393197 |
| 94 | MP0005551_abnormal_eye_electrophysiolog | 1.00018252 |
| 95 | MP0003172_abnormal_lysosome_physiology | 0.97161928 |
| 96 | MP0002882_abnormal_neuron_morphology | 0.96185075 |
| 97 | MP0004145_abnormal_muscle_electrophysio | 0.93908719 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.92870166 |
| 99 | MP0001502_abnormal_circadian_rhythm | 0.91962724 |
| 100 | MP0001485_abnormal_pinna_reflex | 0.91817930 |
| 101 | MP0002653_abnormal_ependyma_morphology | 0.91745514 |
| 102 | MP0004484_altered_response_of | 0.91530090 |
| 103 | MP0003950_abnormal_plasma_membrane | 0.88080328 |
| 104 | MP0004215_abnormal_myocardial_fiber | 0.85217382 |
| 105 | MP0003045_fibrosis | 0.84536841 |
| 106 | MP0005167_abnormal_blood-brain_barrier | 0.82558190 |
| 107 | MP0003011_delayed_dark_adaptation | 0.81605861 |
| 108 | MP0003121_genomic_imprinting | 0.81576262 |
| 109 | MP0001800_abnormal_humoral_immune | 0.81512140 |
| 110 | MP0003137_abnormal_impulse_conducting | 0.81270585 |
| 111 | MP0004811_abnormal_neuron_physiology | 0.81115687 |
| 112 | MP0002095_abnormal_skin_pigmentation | 0.79770361 |
| 113 | MP0005451_abnormal_body_composition | 0.79631159 |
| 114 | MP0005310_abnormal_salivary_gland | 0.79209888 |
| 115 | MP0010678_abnormal_skin_adnexa | 0.78250966 |
| 116 | MP0009764_decreased_sensitivity_to | 0.77728522 |
| 117 | MP0003878_abnormal_ear_physiology | 0.76157832 |
| 118 | MP0005377_hearing/vestibular/ear_phenot | 0.76157832 |
| 119 | MP0000631_abnormal_neuroendocrine_gland | 0.75044603 |
| 120 | MP0002277_abnormal_respiratory_mucosa | 0.73419833 |
| 121 | MP0003868_abnormal_feces_composition | 0.72933685 |
| 122 | MP0000230_abnormal_systemic_arterial | 0.72764425 |
| 123 | MP0001963_abnormal_hearing_physiology | 0.72403621 |
| 124 | MP0004130_abnormal_muscle_cell | 0.71925712 |
| 125 | MP0008872_abnormal_physiological_respon | 0.71672154 |
| 126 | MP0001765_abnormal_ion_homeostasis | 0.71322164 |
| 127 | MP0005075_abnormal_melanosome_morpholog | 0.70403612 |
| 128 | MP0001835_abnormal_antigen_presentation | 0.69274107 |
| 129 | MP0000639_abnormal_adrenal_gland | 0.68628372 |
| 130 | MP0002069_abnormal_eating/drinking_beha | 0.67202055 |
| 131 | MP0002752_abnormal_somatic_nervous | 0.67014084 |
| 132 | MP0005171_absent_coat_pigmentation | 0.66826875 |
| 133 | MP0005410_abnormal_fertilization | 0.66765247 |
| 134 | MP0000609_abnormal_liver_physiology | 0.65917629 |
| 135 | MP0000747_muscle_weakness | 0.65118820 |
| 136 | MP0005166_decreased_susceptibility_to | 0.63398770 |
| 137 | MP0002184_abnormal_innervation | 0.61731578 |
| 138 | MP0004858_abnormal_nervous_system | 0.60341604 |
| 139 | MP0004085_abnormal_heartbeat | 0.59407098 |
| 140 | MP0002837_dystrophic_cardiac_calcinosis | 0.58804101 |
| 141 | MP0002295_abnormal_pulmonary_circulatio | 0.57237606 |
| 142 | MP0001299_abnormal_eye_distance/ | 0.55643477 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 5.29763221 |
| 2 | Myokymia (HP:0002411) | 4.70488727 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.19901271 |
| 4 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.19901271 |
| 5 | Cerebral inclusion bodies (HP:0100314) | 4.17098640 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.04402048 |
| 7 | Febrile seizures (HP:0002373) | 3.97916518 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 3.76955877 |
| 9 | Supranuclear gaze palsy (HP:0000605) | 3.72154609 |
| 10 | Focal motor seizures (HP:0011153) | 3.67779103 |
| 11 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.65389499 |
| 12 | Pancreatic cysts (HP:0001737) | 3.61332856 |
| 13 | Abnormality of the corticospinal tract (HP:0002492) | 3.58433736 |
| 14 | Congenital stationary night blindness (HP:0007642) | 3.58177135 |
| 15 | Deep venous thrombosis (HP:0002625) | 3.54395334 |
| 16 | Complement deficiency (HP:0004431) | 3.51791683 |
| 17 | Intention tremor (HP:0002080) | 3.42130453 |
| 18 | Gaze-evoked nystagmus (HP:0000640) | 3.37875107 |
| 19 | Genetic anticipation (HP:0003743) | 3.35289661 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 3.34630272 |
| 21 | Xanthomatosis (HP:0000991) | 3.31181981 |
| 22 | Termporal pattern (HP:0011008) | 3.27251363 |
| 23 | Insidious onset (HP:0003587) | 3.27251363 |
| 24 | Pancreatic fibrosis (HP:0100732) | 3.22008993 |
| 25 | Stomach cancer (HP:0012126) | 3.14992979 |
| 26 | Hemiparesis (HP:0001269) | 3.12606200 |
| 27 | True hermaphroditism (HP:0010459) | 3.10142708 |
| 28 | Spastic gait (HP:0002064) | 3.08753029 |
| 29 | Molar tooth sign on MRI (HP:0002419) | 3.08112762 |
| 30 | Abnormality of midbrain morphology (HP:0002418) | 3.08112762 |
| 31 | Hemiplegia (HP:0002301) | 3.06462449 |
| 32 | Peripheral hypomyelination (HP:0007182) | 2.97330400 |
| 33 | Onion bulb formation (HP:0003383) | 2.97014557 |
| 34 | Stomatitis (HP:0010280) | 2.96987632 |
| 35 | Absent speech (HP:0001344) | 2.91890523 |
| 36 | Type II lissencephaly (HP:0007260) | 2.89653325 |
| 37 | Ankle clonus (HP:0011448) | 2.89007972 |
| 38 | Dysmetria (HP:0001310) | 2.88567964 |
| 39 | Abnormality of the renal cortex (HP:0011035) | 2.87625098 |
| 40 | Prolonged partial thromboplastin time (HP:0003645) | 2.82458449 |
| 41 | Action tremor (HP:0002345) | 2.82279019 |
| 42 | Nephronophthisis (HP:0000090) | 2.81126272 |
| 43 | Scanning speech (HP:0002168) | 2.73956288 |
| 44 | Axonal loss (HP:0003447) | 2.69539448 |
| 45 | Abnormality of the renal medulla (HP:0100957) | 2.68281223 |
| 46 | Focal seizures (HP:0007359) | 2.67428301 |
| 47 | Abnormality of binocular vision (HP:0011514) | 2.66930680 |
| 48 | Diplopia (HP:0000651) | 2.66930680 |
| 49 | Inability to walk (HP:0002540) | 2.66447859 |
| 50 | Abolished electroretinogram (ERG) (HP:0000550) | 2.61601899 |
| 51 | Medial flaring of the eyebrow (HP:0010747) | 2.60932919 |
| 52 | Hyperventilation (HP:0002883) | 2.57022016 |
| 53 | Absence seizures (HP:0002121) | 2.48756789 |
| 54 | Optic neuritis (HP:0100653) | 2.48667636 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.48667636 |
| 56 | Widely spaced teeth (HP:0000687) | 2.48378459 |
| 57 | Protruding tongue (HP:0010808) | 2.46845866 |
| 58 | Torticollis (HP:0000473) | 2.46514916 |
| 59 | Progressive inability to walk (HP:0002505) | 2.46324744 |
| 60 | Postural instability (HP:0002172) | 2.39030375 |
| 61 | Abnormal drinking behavior (HP:0030082) | 2.38274205 |
| 62 | Polydipsia (HP:0001959) | 2.38274205 |
| 63 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.37941509 |
| 64 | Limb dystonia (HP:0002451) | 2.37062278 |
| 65 | Sensory axonal neuropathy (HP:0003390) | 2.36471410 |
| 66 | Papilledema (HP:0001085) | 2.36093056 |
| 67 | Amyloidosis (HP:0011034) | 2.35060820 |
| 68 | Hypobetalipoproteinemia (HP:0003563) | 2.34549629 |
| 69 | Fair hair (HP:0002286) | 2.31147868 |
| 70 | Congenital sensorineural hearing impairment (HP:0008527) | 2.30749437 |
| 71 | Attenuation of retinal blood vessels (HP:0007843) | 2.30402077 |
| 72 | Cerebral hemorrhage (HP:0001342) | 2.28734884 |
| 73 | Neuronal loss in central nervous system (HP:0002529) | 2.28451850 |
| 74 | Systemic lupus erythematosus (HP:0002725) | 2.27970463 |
| 75 | Gait imbalance (HP:0002141) | 2.27517291 |
| 76 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.26999802 |
| 77 | Clumsiness (HP:0002312) | 2.26406286 |
| 78 | Epileptic encephalopathy (HP:0200134) | 2.25882947 |
| 79 | Agitation (HP:0000713) | 2.25277339 |
| 80 | Epidermoid cyst (HP:0200040) | 2.25152004 |
| 81 | Fat malabsorption (HP:0002630) | 2.23633600 |
| 82 | Mutism (HP:0002300) | 2.23021595 |
| 83 | Large for gestational age (HP:0001520) | 2.19415301 |
| 84 | Ketosis (HP:0001946) | 2.19126297 |
| 85 | Craniofacial dystonia (HP:0012179) | 2.16326461 |
| 86 | Spastic tetraparesis (HP:0001285) | 2.16178455 |
| 87 | Glomerulonephritis (HP:0000099) | 2.15947444 |
| 88 | Focal dystonia (HP:0004373) | 2.12912912 |
| 89 | Parakeratosis (HP:0001036) | 2.11830845 |
| 90 | Drooling (HP:0002307) | 2.11816986 |
| 91 | Abnormality of complement system (HP:0005339) | 2.11793949 |
| 92 | Cystic liver disease (HP:0006706) | 2.10287653 |
| 93 | Blue irides (HP:0000635) | 2.09749369 |
| 94 | Metabolic alkalosis (HP:0200114) | 2.09042306 |
| 95 | Decreased central vision (HP:0007663) | 2.08510871 |
| 96 | Generalized hypopigmentation of hair (HP:0011358) | 2.06847132 |
| 97 | Generalized tonic-clonic seizures (HP:0002069) | 2.06699675 |
| 98 | Excessive salivation (HP:0003781) | 2.06618978 |
| 99 | Dysdiadochokinesis (HP:0002075) | 2.06466913 |
| 100 | Anxiety (HP:0000739) | 2.06402022 |
| 101 | Renal cortical cysts (HP:0000803) | 2.06328391 |
| 102 | Pheochromocytoma (HP:0002666) | 2.06121637 |
| 103 | Peripheral demyelination (HP:0011096) | 2.05726706 |
| 104 | Polyphagia (HP:0002591) | 2.05317379 |
| 105 | Chronic hepatic failure (HP:0100626) | 2.05184380 |
| 106 | Urinary urgency (HP:0000012) | 2.05119369 |
| 107 | Lower limb muscle weakness (HP:0007340) | 2.04945369 |
| 108 | Hypophosphatemic rickets (HP:0004912) | 2.03793014 |
| 109 | Atonic seizures (HP:0010819) | 2.03407309 |
| 110 | Clonus (HP:0002169) | 2.02970989 |
| 111 | Furrowed tongue (HP:0000221) | 2.01247890 |
| 112 | Orchitis (HP:0100796) | 2.01056272 |
| 113 | Lissencephaly (HP:0001339) | 2.00523649 |
| 114 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.99490854 |
| 115 | Congenital primary aphakia (HP:0007707) | 1.97777542 |
| 116 | Akinesia (HP:0002304) | 1.97386288 |
| 117 | Thyroiditis (HP:0100646) | 1.96404306 |
| 118 | Split foot (HP:0001839) | 1.96026855 |
| 119 | Abnormality of methionine metabolism (HP:0010901) | 1.95980369 |
| 120 | Hypochromic microcytic anemia (HP:0004840) | 1.95905762 |
| 121 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.93835987 |
| 122 | Aplasia involving bones of the extremities (HP:0009825) | 1.93197438 |
| 123 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.93197438 |
| 124 | Aplasia of the phalanges of the hand (HP:0009802) | 1.93197438 |
| 125 | Thickened helices (HP:0000391) | 1.91502682 |
| 126 | Retinal atrophy (HP:0001105) | 1.91486664 |
| 127 | Spastic paraparesis (HP:0002313) | 1.91306371 |
| 128 | Tubular atrophy (HP:0000092) | 1.90967118 |
| 129 | Slow saccadic eye movements (HP:0000514) | 1.90755104 |
| 130 | Keratoconus (HP:0000563) | 1.89815190 |
| 131 | Increased corneal curvature (HP:0100692) | 1.89815190 |
| 132 | Myositis (HP:0100614) | 1.89116889 |
| 133 | Polyuria (HP:0000103) | 1.88954660 |
| 134 | Hypokalemic alkalosis (HP:0001949) | 1.88681833 |
| 135 | Abnormality of glycine metabolism (HP:0010895) | 1.88503012 |
| 136 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.88503012 |
| 137 | Generalized myoclonic seizures (HP:0002123) | 1.87641936 |
| 138 | Steatorrhea (HP:0002570) | 1.87172798 |
| 139 | Nephrogenic diabetes insipidus (HP:0009806) | 1.86173158 |
| 140 | Conjugated hyperbilirubinemia (HP:0002908) | 1.85514742 |
| 141 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.85035054 |
| 142 | Decreased circulating renin level (HP:0003351) | 1.84264351 |
| 143 | Pendular nystagmus (HP:0012043) | 1.83982288 |
| 144 | Epileptiform EEG discharges (HP:0011182) | 1.83855272 |
| 145 | Increased circulating renin level (HP:0000848) | 1.83619915 |
| 146 | Abnormality of the periventricular white matter (HP:0002518) | 1.83003806 |
| 147 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.82801255 |
| 148 | Dialeptic seizures (HP:0011146) | 1.82791439 |
| 149 | Depression (HP:0000716) | 1.82234673 |
| 150 | Rigidity (HP:0002063) | 1.82139937 |
| 151 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.82067785 |
| 152 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.82067785 |
| 153 | Abnormality of glycolipid metabolism (HP:0010969) | 1.82067785 |
| 154 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.81735876 |
| 155 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.81212953 |
| 156 | Paraparesis (HP:0002385) | 1.80950418 |
| 157 | Hammertoe (HP:0001765) | 1.80530653 |
| 158 | Hypomagnesemia (HP:0002917) | 1.80452976 |
| 159 | Abnormality of T cell number (HP:0011839) | 1.79788419 |
| 160 | Hyperammonemia (HP:0001987) | 1.79522313 |
| 161 | Dyskinesia (HP:0100660) | 1.78880577 |
| 162 | Broad-based gait (HP:0002136) | 1.78626099 |
| 163 | Abnormality of the common coagulation pathway (HP:0010990) | 1.78050890 |
| 164 | Megalencephaly (HP:0001355) | 1.77802241 |
| 165 | Hypothermia (HP:0002045) | 1.77441071 |
| 166 | Metaphyseal dysplasia (HP:0100255) | 1.77252264 |
| 167 | Abnormality of macular pigmentation (HP:0008002) | 1.77192395 |
| 168 | Bowel incontinence (HP:0002607) | 1.77093445 |
| 169 | Abnormal gallbladder physiology (HP:0012438) | 1.76618388 |
| 170 | Cholecystitis (HP:0001082) | 1.76618388 |
| 171 | Hyperglycinemia (HP:0002154) | 1.76117217 |
| 172 | Keratoconjunctivitis (HP:0001096) | 1.76106889 |
| 173 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.75877086 |
| 174 | Urinary incontinence (HP:0000020) | 1.75794769 |
| 175 | Confusion (HP:0001289) | 1.75249398 |
| 176 | Truncal ataxia (HP:0002078) | 1.74448942 |
| 177 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.74012453 |
| 178 | Abnormal eating behavior (HP:0100738) | 1.73341603 |
| 179 | EEG with generalized epileptiform discharges (HP:0011198) | 1.71987797 |
| 180 | Congenital, generalized hypertrichosis (HP:0004540) | 1.69526601 |
| 181 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.69184019 |
| 182 | Hypsarrhythmia (HP:0002521) | 1.69040007 |
| 183 | T lymphocytopenia (HP:0005403) | 1.68812340 |
| 184 | Congenital hepatic fibrosis (HP:0002612) | 1.67142035 |
| 185 | Visual hallucinations (HP:0002367) | 1.67075021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.39755962 |
| 2 | EPHA4 | 4.30351013 |
| 3 | STK39 | 4.15650328 |
| 4 | OXSR1 | 2.97726671 |
| 5 | NTRK3 | 2.44864355 |
| 6 | TAOK3 | 2.42092566 |
| 7 | ACVR1B | 2.23431840 |
| 8 | EPHB1 | 2.21523112 |
| 9 | NTRK1 | 2.14864022 |
| 10 | MAP3K9 | 2.14754724 |
| 11 | ADRBK2 | 2.12333328 |
| 12 | TXK | 2.10955865 |
| 13 | BMPR1B | 2.10114282 |
| 14 | PKN1 | 1.95350929 |
| 15 | KSR2 | 1.89363664 |
| 16 | RIPK4 | 1.87067545 |
| 17 | WNK3 | 1.86523216 |
| 18 | FGFR2 | 1.85864286 |
| 19 | TNIK | 1.80357000 |
| 20 | MAP3K13 | 1.74457438 |
| 21 | MAP4K2 | 1.66596529 |
| 22 | DAPK2 | 1.61653761 |
| 23 | PAK6 | 1.61527787 |
| 24 | CASK | 1.44864267 |
| 25 | MARK1 | 1.43908924 |
| 26 | MAPK15 | 1.41845710 |
| 27 | SGK494 | 1.40416158 |
| 28 | SGK223 | 1.40416158 |
| 29 | WNK4 | 1.37811426 |
| 30 | MAP3K2 | 1.36146211 |
| 31 | SGK2 | 1.34604150 |
| 32 | MAP3K4 | 1.34087562 |
| 33 | PRPF4B | 1.32513263 |
| 34 | GRK1 | 1.31814756 |
| 35 | WNK1 | 1.27030082 |
| 36 | CAMK2B | 1.24927864 |
| 37 | CDK5 | 1.22491480 |
| 38 | NEK6 | 1.21606606 |
| 39 | MAP2K4 | 1.18293546 |
| 40 | TNK2 | 1.17600089 |
| 41 | PHKG1 | 1.17245505 |
| 42 | PHKG2 | 1.17245505 |
| 43 | PDPK1 | 1.16230283 |
| 44 | MAPKAPK5 | 1.12532278 |
| 45 | FES | 1.12365599 |
| 46 | BCR | 1.11956115 |
| 47 | MINK1 | 1.11676291 |
| 48 | FGR | 1.07449240 |
| 49 | TYRO3 | 1.05491966 |
| 50 | MET | 1.03572448 |
| 51 | PLK2 | 1.03256975 |
| 52 | NTRK2 | 1.02821029 |
| 53 | UHMK1 | 1.01208921 |
| 54 | CAMKK1 | 0.98513018 |
| 55 | CAMK2A | 0.96392566 |
| 56 | ADRBK1 | 0.95591722 |
| 57 | CAMK2D | 0.94304127 |
| 58 | PRKCH | 0.94275052 |
| 59 | NUAK1 | 0.93582862 |
| 60 | PDK1 | 0.92196084 |
| 61 | CSNK1G2 | 0.92029912 |
| 62 | ARAF | 0.90755737 |
| 63 | PINK1 | 0.90417340 |
| 64 | CDK19 | 0.89114654 |
| 65 | PAK3 | 0.88908765 |
| 66 | CAMK2G | 0.87744490 |
| 67 | SYK | 0.87440774 |
| 68 | PBK | 0.86452367 |
| 69 | MAP2K7 | 0.85754602 |
| 70 | PRKCQ | 0.84542947 |
| 71 | ICK | 0.83412821 |
| 72 | NLK | 0.82174477 |
| 73 | IRAK2 | 0.82136029 |
| 74 | CSNK1A1L | 0.81545980 |
| 75 | BLK | 0.79570518 |
| 76 | MAPK7 | 0.78066322 |
| 77 | BMPR2 | 0.77735097 |
| 78 | CSNK1G3 | 0.77572447 |
| 79 | TEC | 0.77371419 |
| 80 | GRK6 | 0.77321264 |
| 81 | ITK | 0.77120872 |
| 82 | CAMK1G | 0.76930038 |
| 83 | PRKD3 | 0.76521172 |
| 84 | JAK1 | 0.76258474 |
| 85 | EPHA3 | 0.76117158 |
| 86 | AKT3 | 0.76075078 |
| 87 | ROCK2 | 0.75551363 |
| 88 | OBSCN | 0.75110300 |
| 89 | MARK2 | 0.74823578 |
| 90 | RET | 0.74679484 |
| 91 | BCKDK | 0.74234213 |
| 92 | IKBKE | 0.74089072 |
| 93 | MAPK12 | 0.74083972 |
| 94 | STK38 | 0.73451749 |
| 95 | PRKD1 | 0.72776282 |
| 96 | PDK2 | 0.72601285 |
| 97 | MAP3K7 | 0.70537340 |
| 98 | STK38L | 0.70522106 |
| 99 | MAP4K1 | 0.70209314 |
| 100 | DYRK1A | 0.68575092 |
| 101 | GRK5 | 0.67003606 |
| 102 | FYN | 0.65309799 |
| 103 | PNCK | 0.65180692 |
| 104 | CSNK1G1 | 0.63360008 |
| 105 | PIK3CA | 0.62995532 |
| 106 | PRKCE | 0.61522211 |
| 107 | MAP3K1 | 0.61419480 |
| 108 | STK11 | 0.60913387 |
| 109 | LMTK2 | 0.60269956 |
| 110 | MAP2K6 | 0.59941733 |
| 111 | PRKCG | 0.59886034 |
| 112 | INSRR | 0.59493763 |
| 113 | GRK7 | 0.58684905 |
| 114 | CAMK4 | 0.57954761 |
| 115 | PRKCZ | 0.57917178 |
| 116 | SGK3 | 0.57274209 |
| 117 | PIK3CG | 0.57018110 |
| 118 | ERBB4 | 0.56701301 |
| 119 | LYN | 0.56183913 |
| 120 | CDK14 | 0.55794490 |
| 121 | IRAK1 | 0.55590050 |
| 122 | KIT | 0.55251927 |
| 123 | SIK1 | 0.53600551 |
| 124 | PTK2B | 0.52632574 |
| 125 | MAPK13 | 0.52523109 |
| 126 | CDK15 | 0.51518540 |
| 127 | SGK1 | 0.50969273 |
| 128 | KSR1 | 0.50373274 |
| 129 | LCK | 0.49325746 |
| 130 | CAMK1 | 0.48510514 |
| 131 | JAK2 | 0.48487888 |
| 132 | PRKACA | 0.47788405 |
| 133 | CSK | 0.47785729 |
| 134 | CDK18 | 0.46996852 |
| 135 | IKBKB | 0.44765177 |
| 136 | CSF1R | 0.43409496 |
| 137 | ZAK | 0.42961413 |
| 138 | MARK3 | 0.42126318 |
| 139 | CAMKK2 | 0.41825364 |
| 140 | PRKG1 | 0.41008862 |
| 141 | ERN1 | 0.40832822 |
| 142 | TGFBR1 | 0.40467688 |
| 143 | TLK1 | 0.40331619 |
| 144 | SIK2 | 0.40280583 |
| 145 | CLK1 | 0.40263066 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.59924882 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.58098615 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.25905215 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.12356159 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.05286710 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.05224894 |
| 7 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.03657996 |
| 8 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01445491 |
| 9 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.76718638 |
| 10 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.75246687 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.72348753 |
| 12 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.69908213 |
| 13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.68173714 |
| 14 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.60535524 |
| 15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.59946949 |
| 16 | GABAergic synapse_Homo sapiens_hsa04727 | 1.51248464 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.50570175 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.45751398 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.44012725 |
| 20 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.41491840 |
| 21 | Olfactory transduction_Homo sapiens_hsa04740 | 1.39060194 |
| 22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.37437708 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.33431666 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.28814791 |
| 25 | Morphine addiction_Homo sapiens_hsa05032 | 1.28541542 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.26859515 |
| 27 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.26817014 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.25232701 |
| 29 | Nicotine addiction_Homo sapiens_hsa05033 | 1.23246241 |
| 30 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.21765646 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.21530758 |
| 32 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.21090637 |
| 33 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.20810025 |
| 34 | Circadian entrainment_Homo sapiens_hsa04713 | 1.20572637 |
| 35 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.18978502 |
| 36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.15614492 |
| 37 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.13998936 |
| 38 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.13927792 |
| 39 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.12911700 |
| 40 | Cocaine addiction_Homo sapiens_hsa05030 | 1.12647250 |
| 41 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.11328004 |
| 42 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.10402260 |
| 43 | Salivary secretion_Homo sapiens_hsa04970 | 1.09335927 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.08583165 |
| 45 | Peroxisome_Homo sapiens_hsa04146 | 1.08002553 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.04192541 |
| 47 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.01580316 |
| 48 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01385555 |
| 49 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00772064 |
| 50 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.00723625 |
| 51 | ABC transporters_Homo sapiens_hsa02010 | 1.00195249 |
| 52 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.97013554 |
| 53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.96432874 |
| 54 | Renin secretion_Homo sapiens_hsa04924 | 0.94684561 |
| 55 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94070107 |
| 56 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.93051849 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 0.89964413 |
| 58 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.88797920 |
| 59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.88625502 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.87999134 |
| 61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.87965112 |
| 62 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.87634608 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85780644 |
| 64 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.85725674 |
| 65 | Long-term potentiation_Homo sapiens_hsa04720 | 0.85568187 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83321497 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.82879229 |
| 68 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.82114345 |
| 69 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.80166370 |
| 70 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.78859868 |
| 71 | Insulin secretion_Homo sapiens_hsa04911 | 0.78473923 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78262616 |
| 73 | Long-term depression_Homo sapiens_hsa04730 | 0.77155812 |
| 74 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.75255071 |
| 75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74674379 |
| 76 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.74377793 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74249149 |
| 78 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.74182468 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73510112 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70718863 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.70614080 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.69374255 |
| 83 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.66409114 |
| 84 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.65926625 |
| 85 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.64923683 |
| 86 | Allograft rejection_Homo sapiens_hsa05330 | 0.64672477 |
| 87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64655094 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64566986 |
| 89 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64284913 |
| 90 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.63450309 |
| 91 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.63340427 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.62277968 |
| 93 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.62222977 |
| 94 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.61324560 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.59725607 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58964068 |
| 97 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.58786860 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58472592 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58057734 |
| 100 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.57861448 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.57097909 |
| 102 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.55540630 |
| 103 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55097984 |
| 104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54777094 |
| 105 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.54726709 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54430082 |
| 107 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.53598394 |
| 108 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53197389 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52297792 |
| 110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51568137 |
| 111 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50867823 |
| 112 | Taste transduction_Homo sapiens_hsa04742 | 0.50364635 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.50188891 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.49859687 |
| 115 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49146909 |
| 116 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48970835 |
| 117 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.48946601 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.48431210 |
| 119 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48417462 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.48261434 |
| 121 | Gap junction_Homo sapiens_hsa04540 | 0.47885208 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47834919 |
| 123 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47216231 |
| 124 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47121432 |
| 125 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45780511 |
| 126 | Tuberculosis_Homo sapiens_hsa05152 | 0.45366573 |
| 127 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45198698 |
| 128 | Asthma_Homo sapiens_hsa05310 | 0.45129515 |
| 129 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.45086763 |
| 130 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44824141 |
| 131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42498264 |
| 132 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.42254278 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42197675 |
| 134 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41955528 |
| 135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.41213342 |
| 136 | Platelet activation_Homo sapiens_hsa04611 | 0.41035640 |
| 137 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.40320054 |
| 138 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.40279194 |

